Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Extract:
Based on this comprehensive report published by Gravitas Market Insights, the Immunology market is said to witness a significant growth during the forecast years between 2021 and 2028. Immunology agents or drugs alter the immune response, they do such either by suppressing or improving the immune system. These drugs are used to fight infections, and/or for treating and preventing specific immunological or autoimmune disorders. In developed as well as developing nations, there is a rise in awareness regarding the immunological diseases and increasing incidences of immunological disorders owing to the factors related to the environment are crucial reasons boosting the global immunology market.
Report Scope in detail:
This latest report edition of Immunology market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Immunology market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years.
Immunology Market Segmentation:
By Drug Class
• Fusion Proteins
• Monoclonal antibody (mAb)
• Immunosuppressant
• Polyclonal antibody (pAb)
• Other Drug Class
By Distribution channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Other Distribution channel
By Diseases Indication
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Rheumatoid Arthritis
• Prophylaxis of Organ Rejection
• Inflammatory Bowel Disease
• Plaque Psoriasis
• Others
Regional Coverage
• North America
o United States
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Korea
o Australia
o Southeast Asia
o Rest of Asia-Pacific
• South America
o Brazil
o Argentina
o Colombia
o Rest of South America
• Middle East & Africa
o GCC
o South Africa
o Rest of Middle East & Africa
Competitive Analysis:
Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.
Few of the Key Players Covered in Our Report:
• Janssen Global Service,LLC (Johnson & Johnson)
• Abbvie Inc.
• Amgen Inc.
• F. Hoffmann-La Roche Ltd
• Pfizer Inc.
• Astellas
• Novartis AG
• Merck Sharp & Dohme Corp.
• Bristol-Myers Squibb Company.
• ALLERGAN
• UCB SA
Impact of COVID19:
The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
Section 1: Executive Summary
1.1. Immunology Market Industry 360° outline, Year 2016 - 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. End-User/Diseases Indication Trends
1.5. Regional Trends
Section 2: Market Dynamics - Immunology Market Industry Insights
2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter's Analysis
2.6. Worldwide Industry Landscape, Year 2016 - 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape
2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa
2.10. Competitive Environment
Section 3: Global Immunology Market, By Drug Class
3.1. Segmentation Analysis, By Drug Class, 2016-2028
3.2. Market Share Segmentation Analysis, By Drug Class, 2016-2028
3.3. Fusion Proteins
3.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
3.4. Monoclonal antibody (mAb)
3.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
3.5. Immunosuppressant
3.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
3.6. Polyclonal antibody (pAb)
3.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
3.7. Other Drug Class
3.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 4: Global Immunology Market, By Distribution channel
4.1. Segmentation Analysis, By Distribution channel, 2016-2028
4.2. Market Share Segmentation Analysis, By Distribution channel, 2016-2028
4.3. Retail Pharmacies
4.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.4. Hospital Pharmacies
4.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.5. Online Pharmacies
4.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.6. Other Distribution channel
4.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 5: Global Immunology Market, By Diseases Indication
5.1. Segmentation Analysis, By Diseases Indication, 2016-2028
5.2. Market Share Segmentation Analysis, By Diseases Indication, 2016-2028
5.3. Psoriatic Arthritis
5.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4. Ankylosing Spondylitis
5.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5. Rheumatoid Arthritis
5.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.6. Prophylaxis of Organ Rejection
5.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.7. Inflammatory Bowel Disease
5.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.8. Plaque Psoriasis
5.8.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.9. Others
5.9.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 6: Global Immunology Market, Regional Analysis
6.1. Global Immunology Market, Regional Analysis
6.2. North America, Country level Analysis
6.2.1. North America Immunology Market estimates and forecast with Growth rate analysis, By Drug Class, 2016 - 2028
6.2.2. North America Immunology Market estimates and forecast with Growth rate analysis, By Distribution channel, 2016 - 2028
6.2.3. North America Immunology Market estimates and forecast with Growth rate analysis, By Diseases Indication, 2016 - 2028
6.2.4. United States
6.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.2.5. Canada
6.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.2.6. Mexico
6.2.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.3. Europe Country level Analysis
6.3.1. Europe Immunology Market estimates and forecast with Growth rate analysis, By Drug Class, 2016 - 2028
6.3.2. Europe Immunology Market estimates and forecast with Growth rate analysis, By Distribution channel, 2016 - 2028
6.3.3. Europe Immunology Market estimates and forecast with Growth rate analysis, By Diseases Indication, 2016 - 2028
6.3.4. UK
6.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.3.5. Germany
6.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.3.6. France
6.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.3.7. Italy
6.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.3.8. Spain
6.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.3.9. Russia
6.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.3.10. Rest of Europe
6.3.10.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.4. Asia-Pacific Country level Analysis
6.4.1. Asia-Pacific Immunology Market estimates and forecast with Growth rate analysis, By Drug Class, 2016 - 2028
6.4.2. Asia-Pacific Immunology Market estimates and forecast with Growth rate analysis, By Distribution channel, 2016 - 2028
6.4.3. Asia-Pacific Immunology Market estimates and forecast with Growth rate analysis, By Diseases Indication, 2016 - 2028
6.4.4. China
6.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.4.5. India
6.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.4.6. Japan
6.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.4.7. Korea
6.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.4.8. Australia
6.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.4.9. Southeast Asia
6.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.4.10. Rest of Asia-Pacific
6.4.10.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.5. South America Country level Analysis
6.5.1. South America Immunology Market estimates and forecast with Growth rate analysis, By Drug Class, 2016 - 2028
6.5.2. South America Immunology Market estimates and forecast with Growth rate analysis, By Distribution channel, 2016 - 2028
6.5.3. South America Immunology Market estimates and forecast with Growth rate analysis, By Diseases Indication, 2016 - 2028
6.5.4. Brazil
6.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.5.5. Argentina
6.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.5.6. Colombia
6.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.5.7. Rest of South America
6.5.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.6. Middle East & Africa Country level Analysis
6.6.1. MEA Immunology Market estimates and forecast with Growth rate analysis, By Drug Class, 2016 - 2028
6.6.2. MEA Immunology Market estimates and forecast with Growth rate analysis, By Distribution channel, 2016 - 2028
6.6.3. MEA Immunology Market estimates and forecast with Growth rate analysis, By Diseases Indication, 2016 - 2028
6.6.4. GCC
6.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.6.5. South Africa
6.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
6.6.6. Rest of Middle East & Africa
6.6.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 7: Company Profile - Immunology Market
7.1. Janssen Global Service,LLC (Johnson & Johnson)
7.1.1. Business Overview
7.1.2. Product & Service Offering
7.1.3. Overall Revenue
7.1.4. Strategic Outlook
7.2. Abbvie Inc.
7.2.1. Business Overview
7.2.2. Product & Service Offering
7.2.3. Overall Revenue
7.2.4. Strategic Outlook
7.3. Amgen Inc.
7.3.1. Business Overview
7.3.2. Product & Service Offering
7.3.3. Overall Revenue
7.3.4. Strategic Outlook
7.4. F. Hoffmann-La Roche Ltd
7.4.1. Business Overview
7.4.2. Product & Service Offering
7.4.3. Overall Revenue
7.4.4. Strategic Outlook
7.5. Pfizer Inc.
7.5.1. Business Overview
7.5.2. Product & Service Offering
7.5.3. Overall Revenue
7.5.4. Strategic Outlook
7.6. Astellas
7.6.1. Business Overview
7.6.2. Product & Service Offering
7.6.3. Overall Revenue
7.6.4. Strategic Outlook
7.7. Novartis AG
7.7.1. Business Overview
7.7.2. Product & Service Offering
7.7.3. Overall Revenue
7.7.4. Strategic Outlook
7.8. Merck Sharp & Dohme Corp.
7.8.1. Business Overview
7.8.2. Product & Service Offering
7.8.3. Overall Revenue
7.8.4. Strategic Outlook
7.9. Bristol-Myers Squibb Company.
7.9.1. Business Overview
7.9.2. Product & Service Offering
7.9.3. Overall Revenue
7.9.4. Strategic Outlook
7.10. ALLERGAN
7.10.1. Business Overview
7.10.2. Product & Service Offering
7.10.3. Overall Revenue
7.10.4. Strategic Outlook
7.11. UCB SA
7.11.1. Business Overview
7.11.2. Product & Service Offering
7.11.3. Overall Revenue
7.11.4. Strategic Outlook
*Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028
*Details on financial performance and strategic moves and developments may not be captured for unlisted companies
*List of companies profiled in this TOC is tentative and may change after detailed analysis
Request Sample 
Request Discount 
Inquire Before Buy
